The escalating challenge of vancomycin resistance in Staphylococcus aureus

Area of Science:

• Microbiology and Infectious Diseases
• Molecular Biology
• Pharmacology

Background:

• Vancomycin is crucial for treating multidrug-resistant Staphylococcus aureus (MRSA).
• The emergence of vancomycin resistance in S. aureus was a significant clinical concern.
• Initial vancomycin-intermediate S. aureus (VISA) isolates appeared without evidence of genetic exchange.

Purpose of the Study:

• To review the evolving characteristics of the VISA phenotype.
• To elucidate the molecular mechanisms underlying VISA resistance, focusing on genetic regulation and cell wall stress.
• To summarize current knowledge on vancomycin-resistant S. aureus (VRSA) and discuss alternative therapies.

Main Methods:

• Literature review of clinical isolates and molecular studies.
• Analysis of genetic regulation and cell wall stress response pathways.
• Summary of available and emerging alternative antibiotics.

Main Results:

• VISA exhibits variable resistance characteristics and arises through novel mechanisms.
• VRSA emerged later, acquiring high-level resistance via enterococcal vanA elements on plasmids.
• Understanding resistance mechanisms is key to developing effective treatments.

Conclusions:

• The development of vancomycin resistance in S. aureus is complex and multifaceted.
• Further research into VISA/VRSA mechanisms is essential for clinical management.
• Alternative antibiotics are needed, but their limitations and resistance potential require careful consideration.